Cerebral microdialysis in neurointensive care patients to determine brain penetration of antibiotics. An open label explorative study.

Med. Univ. Wien, Uk für Innere Medizin I0 个研究点开始时间: 2012年4月10日最近更新: 2015年7月10日

适应症

试验速览

暂无简介。

•Patient age > 18 years
•Application of brain microdialysis as standard care
•Clinical indication for antimicrobial treatment due to bacterial infection (e.g. pneumonia, cIAI and cUTI, soft tissue infection, bacteriamia) or clinical indication for antibiotic prophylaxis
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•no need of intensive care and bedside cerebral microdialysis as standard care
•no clinical indication for antibiotic therapy or prophylaxis
•impaired renal function (CrCl < 50ml/min)
•Any disease considered relevant for proper performance of the study or risks to the patient, at the discretion of the investigator

发起方

Med. Univ. Wien, Uk für Innere Medizin I